The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:
It is well past time to focus on distinct health disparities among Black, Indigenous, and other people of color (BIPOC) and Latinx communities, especially given the CDC’s recent, welcome focus on health disparities and equity.
The latest edition of Protecting Global Gains, Abiyamo Alayo: Happy Mother Radio Show Takes Community Outreach Further, describes how “mentor mothers” in Nigeria adapted to keep medicines and supplies flowing despite COVID-19 disruptions.
In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN 702, or Uhambo, was halted for lack of efficacy.
AVAC has a new resource to support advocacy for multipurpose prevention technologies (MPTs), Advocates' Guide to Multipurpose Prevention Technologies.
AVAC has an extensive online resource library with hundreds of Reports, Publications, Infographics & more. And it includes powerful search features to find exactly what you’re looking for.
AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more
AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.